acetylcysteine has been researched along with metoprolol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Varol, E; Yucel, H | 1 |
| Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Sutcu, R; Uysal, BA; Varol, E; Yucel, H | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, T; Uysal, BA; Varol, E; Yucel, H | 1 |
| Ibanez, B; Lobo-Gonzalez, M; Rossello, X | 1 |
| Cheng, M; Guo, X; Hu, Z; Li, X; Peng, Y; Wang, Y; Xing, G; Zheng, J | 1 |
2 review(s) available for acetylcysteine and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
Topics: Acetylcysteine; Acute Disease; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Animals; Cardiotonic Agents; Exenatide; Free Radical Scavengers; Humans; Hypoglycemic Agents; Incidence; Metoprolol; Mice; Mice, Transgenic; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction | 2019 |
3 trial(s) available for acetylcysteine and metoprolol
| Article | Year |
|---|---|
Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Humans; Length of Stay; Metoprolol; Middle Aged; Postoperative Complications; Propanolamines; Treatment Outcome; Young Adult | 2013 |
Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.
Topics: Acetylcysteine; Aged; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Oxidative Stress; Postoperative Period; Propanolamines; Prospective Studies; Treatment Outcome | 2014 |
Addition of N-acetyl cysteine to carvedilol decreases the incidence of acute renal injury after cardiac surgery.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Creatinine; Double-Blind Method; Female; Humans; Incidence; Male; Metoprolol; Middle Aged; Propanolamines; Prospective Studies; Time Factors; Treatment Outcome; Turkey | 2014 |
5 other study(ies) available for acetylcysteine and metoprolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of Metoprolol Tartrate-Derived Reactive Metabolites Possibly Correlated with Its Cytotoxicity.
Topics: Acetylcysteine; Animals; Glutathione; Metoprolol; Microsomes, Liver; Rats | 2022 |